[PDF] Top 20 <p>Thunderstorm-triggered asthma: what we know so far</p>
Has 10000 "<p>Thunderstorm-triggered asthma: what we know so far</p>" found on our website. Below are the top 20 most common "<p>Thunderstorm-triggered asthma: what we know so far</p>".
<p>Thunderstorm-triggered asthma: what we know so far</p>
... The factors that contribute to rapid changes in weather and the ability to understand whether these can be reliably predicted over time remain a priority. The ability to accu- rately predict thunderstorms and a TA ... See full document
8
<p>Electronic cigarettes and cardiovascular health: what do we know so far?</p>
... risk. We quanti fi ed in fl ammation using 18 fl uorodeoxyglucose positron-emission tomography in 31 participants (TC smokers, EC users, and nonsmo- kers) in hematopoietic and vascular tissues, components of the ... See full document
16
The Impacts of Covid-19 to Small Scale Fisheries in Tun Mustapha Park, Sabah, Malaysia; What Do We Know So Far?
... The movement control measures have outsized the impacts on the fisheries industry along the food supply chain. A large section of the market for fresh fish and shellfish are also affected, triggering a decline in fish ... See full document
13
<p>Vitamin E and Alzheimer’s disease: what do we know so far?</p>
... 75 The study reported signi fi cantly diminished plasma vitamin E levels for each isoform in those with AD compared to controls and low tocopherol and tocotrienol levels were associated w[r] ... See full document
15
<p>Cognitive Impairment in Parkinson’s Disease: What We Know so Far</p>
... striatal impairment (disturbances in planning, working mem- ory, and response inhibition), modulated by dopamine, that may be present even in very early phases of PD and fre- quently with little progression over time; 2) ... See full document
11
<p>Anesthesia Options and the Recurrence of Cancer: What We Know so Far?</p>
... Because of the anti-metastatic effects of TIVA in experimen- tal conditions, there has been a growing interest in translating such bene fi cial effects into human studies. 6,9,85,125,128-142 The most extensive study was ... See full document
16
Acute hydrated non-compressive nucleus pulposus extrusion: what do we know so far?
... findings with outcome in dogs with presumptive acute noncompressive nucleus pulposus 97. extrusion: 42 cases (2000–2007)[r] ... See full document
5
<p>The effects of huntingtin-lowering: what do we know so far?</p>
... primates, what has been found in the Ionis Pharmaceutical safety trial of a huntingtin-lowering therapy, and to the question of how much mutant huntingtin may need to be lowered for a therapy to be clinically ... See full document
15
The Environment: An Agricultural Perspective on What We Know and What We Need to Know
... The three-stratum forage system has been developed over nine-and-a half years to match the low rainfall environment (600–900mm annual rainfall and 4 to 8 months of dry season) in Bali, Indonesia. The concept integrates ... See full document
20
Microplastics in freshwater ecosystems: what we know and what we need to know
... In a field report, Sanchez et al. [51] provide the only data on MP in freshwater fish so far. They investigated gudgeon (Gobio gobio) caught in 11 French streams and found MP in the digestive tract of 12% ... See full document
9
Transmission of Ebola Viruses: What We Know and What We Do Not Know
... Breathing, talking, coughing, and sneezing generate particles suspended in air (aerosols), which range in diameter from less than 1 m to greater than 100 m. These particles traditionally have been divided into two ... See full document
10
NEUROLOGICAL COMPLICATIONS OF PANDEMIC COVID-19: What have we got so far?
... Hwang C described, in 2006, a case of complete anosmia three weeks after the onset of the first symptoms of SARS-CoV infection. The patient was a 27 years-old woman who presented with fever, cough, headache, myalgia, and ... See full document
17
Plant hormone transporters: what we know and what we would like to know
... In a targeted approach, Kretzschmar et al. [96] identi- fied PDR1 as a strigolactone transporter in Petunia. Pe- tunia axillaris PDR1 (PaPDR1) was localized to the plasma membrane of the root tip and hypodermal pas- sage ... See full document
15
Infant observation research: What have we learned so far?
... review what has happened since this tentative idea of a research programme was put ...is, what has been achieved by all this in terms of research? What have we learned so far? ... See full document
33
South African exporting firms: What do we know and what should we know?
... exporting far exceed the option value of being in the exporting market, implying that entry and exit amongst these firms is ...important. We do not know how many potential exporters are on the ... See full document
27
Antimalarial metabolization: what have we learnt so far?
... equally respond to a particular drug which supports the genetic basis of drug metabolism. In order to know the genetic basis of gene involved in drug metabolism, the inter-individual variation is very important. ... See full document
10
The impact of economic crises on social inequalities in health: what do we know so far?
... However, some results also show that economic reces- sions are not always accompanied by an increase in so- cial inequalities in health. Indeed, it seems that the role of welfare state policies during periods of ... See full document
6
Experiencing relational depth in therapy : What we know so far
... Participants described powerful feelings of connection, closeness and intimacy with the other at these moments of deep connection (Connelly, 2009; Cooper, 2005; Knox, 2008, 2011; Macleod, 2009; Morris, 2009; Wiggins, ... See full document
15
Bitcoin's return behaviour: What do We know so far?
... today we have more than 2000 cryptocurrencies and many platforms trading them, but only 25 respond for 90% of market ...list we have Bitcoin who was the first and was online in 2009, since them has received ... See full document
8
<p>Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?</p>
... Abstract: Nocturnal hypertension has been recognized as a signi fi cant risk factor for cardio- and cerebrovascular diseases. Blood pressure (BP) monitoring signi fi cantly increased our aware- ness of nocturnal ... See full document
7
Related subjects